Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,360.00
Bid: 12,328.00
Ask: 12,332.00
Change: -4.00 (-0.03%)
Spread: 4.00 (0.032%)
Open: 12,358.00
High: 12,376.00
Low: 12,256.00
Prev. Close: 12,364.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: PM Johnson confirms England lockdown easing on May 17

Mon, 10th May 2021 18:55

(Alliance News) - People in England will be able to hug loved ones, dine in restaurants and go on holiday abroad from next week in a "considerable step on the road back to normality", Prime Minister Boris Johnson has confirmed.

The move to the next stage of the road map out of lockdown on May 17 came as the Covid-19 alert level in the UK was downgraded after a "consistent" fall in cases, hospital admissions and deaths.

The prime minister set out a new approach to tackling the virus, giving people greater responsibility for their own choices on whether to observe social distancing measures with friends and family.

"Today we are taking a step towards that moment when we learn to live responsibly with Covid, when we cease eventually to rely on detailed Government edicts and make our own decisions," he said.

Confirmation that England would move to step three on the road map came from Johnson at a Downing Street press conference after a Cabinet meeting to sign off the change.

The prime minister said: "This unlocking amounts to a very considerable step on the road map to normality and I am confident that we will be able to go further."

The road map remained on track for the next stage on June 21 and Johnson promised that later this month the government would set out "what role there could be – if any – for certification and social distancing".

The government has been reviewing whether Covid status certification, recording whether people have had a vaccine or negative test result, could be used to help open up businesses and Johnson's comments could be a hint they are no longer a priority.

Johnson said the current data indicated that it might be possible to scrap the "one-metre plus" rule, something which would greatly increase flexibility for businesses to increase capacity.

From May 17:

– People will be able to meet outdoors in groups of up to 30.

– People will be able to meet indoors in groups of six, or two households.

– Pubs and restaurants will be able to serve customers indoors, although they will be limited to table service.

– Cinemas, museums, theatres and concert halls will be allowed to reopen although there will be capacity limits on large events.

– The "stay in the UK" restriction will lift and people will be able to travel to "green list" countries, such as Portugal although they are still being advised not to go to destinations on the amber list.

– Up to 30 people will be allowed at weddings, although dancing will still not be allowed, and the cap on the number of mourners attending funerals will be lifted, in line with the safe capacity of the venue.

– Secondary school pupils will no longer be told to wear face masks in class and communal areas.

– University students will return to campus for in-person lectures.

The easing of restrictions came after the UK's senior medics said the Covid-19 alert level should be lowered from "level 4" to "level 3", meaning that while the epidemic is in general circulation, transmission is no longer deemed to be high or rising exponentially.

But England's chief medical officer Professor Chris Whitty urged particular caution around the Indian variant which has been detected in increasing numbers in the UK.

From a low level "it has gone up very sharply" he said, warning that it was possibly more transmissible than the Kent variant which swept across the UK in the winter.

But "at this point in time our view is that it is less likely to be able to escape vaccination than some of the other variants".

Up to May 5, some 520 confirmed or probable cases of the Indian strain had been identified, an increase of 318 in a week.

The latest figures showed that up to May 9, 35.5 million people have had a first dose of vaccine, a rise of 100,626 on the previous day, while 17.9 million of those have now also had a second doses, an increase of 187,171.

A further four people died within 28 days of testing positive for Covid-19 as of Monday, bringing the UK total by that measure to 127,609.

The figures on the government dashboard showed none of the new deaths reported on Monday were in England, Scotland or Northern Ireland but there is often a lag in data following a weekend.

The government also said that, as of 0900 BST on Monday, there had been a further 2,357 lab-confirmed cases in the UK, bringing the total to 4.44 million.

Meanwhile, BioNTech SE has said its Covid-19 vaccine with Pfizer SE does not need to be tweaked to tackle variants of the virus currently in circulation.

But it said that it has a strategy to "address these variants should the need arise in the future".

In further positive news, analysis by Public Health England found a single dose of the AstraZeneca PLC vaccine reduces the risk of death with Covid-19 by approximately 80% – and two doses of Pfizer cut it by 97%.

By David Hughes, PA Political Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
26 Mar 2024 10:18

China to speed up 'new productive forces', vice president says

BEIJING, March 26 (Reuters) - China will accelerate the development of "new productive forces" and bolster stability and security for the global economy, Vice President Han Zheng told an investment forum in Beijing, as the world's no.2 economy seeks to reassure anxious foreign firms.

Read more
25 Mar 2024 12:09

LONDON MARKET MIDDAY: Stocks make tepid start to new week

(Alliance News) - Stock prices in London were down at midday on Monday, giving back some gains from last week, when equities were boosted by central bank decisions and accompanying statements which investors saw as dovish.

Read more
25 Mar 2024 09:04

LONDON MARKET OPEN: FTSE 100 treads water, FTSE 250 declines

(Alliance News) - The FTSE 100 in London traded flat early Monday, while the pound remained below the USD1.26 mark, as Bank of England Governor Andrew Bailey suggested rate cuts may happen soon.

Read more
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.